NMD Pharma has secured cash to muscle into the myasthenia gravis (MG) market. With Novo Holdings and Roche Venture Fund joining a syndicate led by Jeito Capital, the biotech has raised 35 million ...

If you’re looking for a sneaker that can handle long city walks, you may want an option that’s easy on your feet and the planet. Enter the Adidas NMD V3, a sustainable sneaker designed for city ...

NMD Pharma A/S has announced top-line results showing its orally available ion channel inhibitor, NMD-670, has a positive clinical impact in myasthenia gravis (MG), with patients having stronger hand ...

PARIS--(BUSINESS WIRE)--Jeito Capital (“Jeito”), a leading independent Private Equity firm dedicated to biotech and biopharma, today announces that it has become a key investor as part of a €35 ...

While the NMD took sneaker culture by storm, the momentum around Adidas had been building for months prior. There were several moments and strategic moves that helped usher in the era of the NMD. Ye’s ...